Immediate Impact
27 from Science/Nature 73 standout
Citing Papers
Tumor microenvironment-responsive engineered hybrid nanomedicine for photodynamic-immunotherapy via multi-pronged amplification of reactive oxygen species
2025 Standout
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
2023 Standout
Works of Les Henderson being referenced
A phase IB/randomized phase II study of gemcitabine (G) plus placebo (P) or vismodegib (V), a hedgehog (Hh) pathway inhibitor, in patients (pts) with metastatic pancreatic cancer (PC): Interim analysis of a University of Chicago phase II consortium study.
2012
Durable Complete Response of Metastatic Gastric Cancer with Anti-Met Therapy Followed by Resistance at Recurrence
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Les Henderson | 138 | 52 | 147 | 76 | 19 | 329 | |
| Jingbo Kang | 83 | 42 | 118 | 61 | 20 | 304 | |
| Arpita Singha Roy | 84 | 56 | 195 | 41 | 14 | 334 | |
| Enrico Di Oto | 101 | 45 | 79 | 127 | 21 | 285 | |
| Weiwen Fan | 98 | 66 | 136 | 81 | 21 | 316 | |
| Tsong‐Hong Kuo | 178 | 62 | 96 | 43 | 20 | 350 | |
| Ke Yang | 89 | 131 | 122 | 142 | 28 | 327 | |
| Joanna Vermeij | 135 | 74 | 112 | 81 | 22 | 282 | |
| Bhupesh Parashar | 70 | 18 | 145 | 43 | 17 | 332 | |
| IHM Borel Rinkes | 142 | 31 | 162 | 33 | 11 | 340 | |
| Carol W. Johnson | 62 | 17 | 139 | 32 | 16 | 306 |
All Works
Login with ORCID to disown or claim papers
Loading papers...